Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2012
12/05/2012CN102811782A 免疫球蛋白G Fc区结合多肽 Immunoglobulin G Fc region binding polypeptides
12/05/2012CN102811736A Humanized Anti-IL-10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (SLE)
12/05/2012CN102807618A Preparation method of phenytoin homogeneous enzyme immunoassay kit and phenytoin polyclonal antibodies
12/05/2012CN102807617A Antibodies to M-CSF
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102807488A Hapten and antigen universally used for ether pyrethroid pesticide, and synthesis method and application of hapten and antigen
12/05/2012CN102805861A Lactate dehydrogenase A acetylation activator and application thereof
12/05/2012CN102226153B Preparation method of immunogen for generating infectious microbe antiserum
12/05/2012CN101974072B Escherichia coli TolC antigen as well as antibody and application thereof
12/05/2012CN101885757B Avian influenza hemagglutinin, epitope peptide, monoclonal antibodies for resisting avian influenza hemagglutinin and epitope peptide, and applications of monoclonal antibodies
12/05/2012CN101659703B Monoclonal antibody of anti-human BAP31 protein, preparation method and application thereof
12/05/2012CN101659702B Monoclonal antibody of anti-human calnexin protein, preparation method and application thereof
12/05/2012CN101495636B DNA vaccine for koi herpes virus (KHV) disease
12/05/2012CN101386641B Synthetic peptide vaccines for foot-and-mouth disease
12/05/2012CN101133158B 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use
12/05/2012CN101014626B Glycosylated immunoglobulin and immunoadhesin comprising the same
12/04/2012US8324363 Microarray for detection of the deletion of exon 3 of the G-CSF gene
12/04/2012US8324355 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
12/04/2012US8324354 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
12/04/2012US8324353 Chimeric immunoreceptor useful in treating human gliomas
12/04/2012US8324352 Anti-inflammatory antibodies and uses therefor
12/04/2012US8324351 Fc variants with altered binding to FcRn
12/04/2012US8324350 Dual-specific IL-1α/IL-1β antibodies
12/04/2012US8324347 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
12/04/2012US8324344 Membrane transduction peptides and methods of delivering material to a target cell
12/04/2012US8324190 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
12/04/2012US8323964 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012US8323959 Microorganisms for therapy
12/04/2012US8323918 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
12/04/2012US8323916 Method of detecting endometrial cancer comprising measuring levels of fibrocystin-L
12/04/2012US8323910 Methods and compositions for determining the purity of chemically synthesized nucleic acids
12/04/2012US8323885 Using allelic variation aristaless homeobox gene (ARX) as diagnostic tool in detection of convulsive and learning disorders
12/04/2012US8323660 Method for identification, isolation and production of antigens to a specific pathogen
12/04/2012US8323654 Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
12/04/2012US8323653 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
12/04/2012US8323651 Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
12/04/2012US8323647 Humanized antibodies against the β-amyloid peptide
12/04/2012US8323646 Engineered anti-IL-13 antibodies, compositions, methods and uses
12/04/2012US8323645 Antibodies that bind OV064 and methods of use therefor
12/04/2012US8323644 Therapy-enhancing glucan
12/04/2012CA2718302C Methods for producing enantiomerically pure .alpha.-substituted carboxylic acids
12/04/2012CA2626120C Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
12/04/2012CA2532966C Igm production by transformed cells and methods for quantifying said igm production
12/04/2012CA2525139C Cd20 binding molecules
12/04/2012CA2495570C Immunostimulatory compositions and methods of stimulating an immune response
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2443345C Disease-associated protein
12/04/2012CA2400868C Anti-egfrviii scfvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
12/04/2012CA2371714C Streptococcus pneumoniae proteins and vaccines
12/04/2012CA2349442C Compositions and methods for wt1 specific immunotherapy
12/04/2012CA2340304C Multicomponent vaccines
12/04/2012CA2261630C Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease
12/04/2012CA2210484C Composition to ameliorate osteolysis and metastasis
11/2012
11/29/2012WO2012162583A1 Design and construction of novel multivalent antibodies
11/29/2012WO2012162561A2 Multivalent and monovalent multispecific complexes and their uses
11/29/2012WO2012162426A1 Methods and compositions for heptameric targeting ligands
11/29/2012WO2012162418A1 Methods and compositions for heterodimeric targeting ligands
11/29/2012WO2012162394A2 Compositions and methods for treating renal disease
11/29/2012WO2012162277A1 METHOD FOR PREPARING Fc-CONTAINING POLYPEPTIDES HAVING IMPROVED PROPERTIES
11/29/2012WO2012162257A2 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/29/2012WO2012162243A2 Anti-cgrp compositions and use thereof
11/29/2012WO2012162160A1 Modified glycoproteins
11/29/2012WO2012161372A1 Double-target antibody fused with a peptide and use of same
11/29/2012WO2012160678A1 Substance for inhibiting infection by human immunodeficiency virus
11/29/2012WO2012160536A1 Antibody purification
11/29/2012WO2012160530A1 Purification of antibodies
11/29/2012WO2012160153A1 Agents for treating tumours
11/29/2012WO2012136534A3 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
11/29/2012WO2012125623A3 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
11/29/2012WO2012102521A3 Human anti-cd23 fab antibody and a pharmaceutical composition for treating tumours comprising same
11/29/2012WO2012075023A3 Neoantibodies for diagnosing tissue injury
11/29/2012WO2011104315A3 Immunoglobulin preparation and storage system for an immunoglobulin preparation
11/29/2012US20120304319 Tox3 as a biomarker for breast cancer
11/29/2012US20120303083 Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease
11/29/2012US20120302740 Vincristine immunoassay
11/29/2012US20120302739 Biological products
11/29/2012US20120302738 Recombinant antibody vector
11/29/2012US20120302737 Coiled coil and/or tether containing protein complexes and uses thereof
11/29/2012US20120302729 Anticancer anti-mortalin peptide antibody
11/29/2012US20120302650 Insulin-Like Growth Factor 1 Receptor (IGF1R) Protein SRM/MRM Assay
11/29/2012US20120302463 Focused libraries of genetic packages
11/29/2012US20120301974 Clozapine Immunoassay
11/29/2012US20120301973 Clozapine immunoassay
11/29/2012US20120301902 Gemcitabine Immunoassay
11/29/2012US20120301901 Gemcitabine immunoassay
11/29/2012US20120301899 Use of novel markers of pluripotent stem cells
11/29/2012US20120301889 Method and reagents for identifying pluripotent stem cells
11/29/2012US20120301879 Novel use of ca-125
11/29/2012US20120301501 Method for selecting and producing vaccine components and vaccines based thereon
11/29/2012US20120301497 Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine
11/29/2012US20120301495 Antigen peptide and use thereof
11/29/2012US20120301490 Immunoconjugates, compositions for making them, and methods of making and use
11/29/2012US20120301489 Jagged-Binding Agents and Uses Thereof
11/29/2012US20120301488 Anti-cd40 antibodies and methods of use
11/29/2012US20120301487 Method for in-vivo binding of chromatin fragments
11/29/2012US20120301484 Regulatory t cell mediator proteins and uses thereof
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301476 Pharmaceutical composition for treating and/or preventing cancer
11/29/2012US20120301475 Novel heparanase splice variant
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 1494